Cachexia is a systemic condition that occurs during many neoplastic diseases, such as
cancer. Cachexia in cancer is characterized by loss of body weight and muscle and by …

Left ventricular hypertrophy is a leading risk factor for cardiovascular morbidity and mortality.
Although reverse ventricular remodelling was long thought to be irreversible, evidence from …

Cachexia is a severe complication of cancer that adversely affects the course of the disease,
with currently no effective treatments. It is characterized by a progressive atrophy of skeletal …

Cancer cachexia is a multifactorial condition characterized by body weight loss that
negatively affects quality of life and survival of patients with cancer. Despite the clinical …

Cardiomyopathy is one of the characteristic features of cancer. In this study, we establish a
suitable model to study breast cancer-induced cardiomyopathy in mice. We used Ehrlich …

Cancer cachexia is a multifactorial syndrome characterized by a progressive loss of skeletal
muscle mass associated with significant functional impairment. In addition to a loss of …

Aims Cachexia is a severe complication of cancer that adversely affects the course of the
disease and is associated with high rates of mortality. Patients with cancer manifest …

Cachexia is a prevalent pathological condition associated with chronic heart failure. Its
occurrence predicts increased morbidity and mortality independent of important clinical …

Breast cancer is the most common malignancy in women of the Western world. Doxorubicin
(DOX) continues to be used extensively to treat early-stage or node-positive breast cancer …

Due to advances in prevention, early detection and treatment, early breast cancer mortality
has decreased by nearly 40% during the last four decades. Yet, the risk of cardiovascular …